Agenus (AGEN) Cash from Operations Growth (3y) (2013 - 2026)
Agenus (AGEN) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 34.32% |
| 10 | Agenus | 230.68 Mn | 195.69 Mn | 33.74 Mn | 14.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.99% |
| Dec 31, 2025 | 29.46% |
| Sep 30, 2025 | 22.93% |
| Jun 30, 2025 | 22.51% |
| Mar 31, 2025 | 21.22% |
| Dec 31, 2024 | -7.71% |
| Sep 30, 2024 | -33.99% |
| Jun 30, 2024 | 11.75% |
| Mar 31, 2024 | 3.68% |
| Dec 31, 2023 | -4.32% |
| Sep 30, 2023 | -27.29% |
| Jun 30, 2023 | -17.12% |
| Mar 31, 2023 | -19.26% |
| Dec 31, 2022 | -14.21% |
| Sep 30, 2022 | -5.03% |
| Jun 30, 2022 | -6.77% |
| Mar 31, 2022 | -38.97% |
| Dec 31, 2021 | 13.80% |
| Sep 30, 2021 | 94.34% |
| Jun 30, 2021 | -22.13% |